 By John Vandermosten, CFA NASDAQ:DYAI Dyadic Announces Partnership with FNLCR Dyadic International, Inc. NASDAQ:DYAI announced in a press release yesterday that Frederick National Laboratory will use Dyadics proprietary protein-expression cell line, C1, for vaccine production. The Frederick National Laboratory for Cancer Research FNLCR is developing several COVID-19 vaccine candidates that 